Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Heart Rhythm. 2013 Oct 4;10(12):10.1016/j.hrthm.2013.09.064. doi: 10.1016/j.hrthm.2013.09.064

Figure 6.

Figure 6

Q7R-FGF12 recapitulates the BrS action potential. A: Representative evoked action potentials from cardiomyocytes of the 4 groups. B and C: Summarized data for action potential peak amplitude and half-width, respectively. *P < .05 versus control; **P < .01 versus control; †P < .01 versus FGF13 KD + WT-FGF12. BrS = Brugada syndrome; CON = control; FGF = fibroblast growth factor; KD = knocked down; WT = wild type.